Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of the American College of Cardiology
|
September 25, 2012
10-year exercise training in chronic heart failure: a randomized controlled trial
Romualdo Belardinelli, Demetrios Georgiou, Giovanni Cianci, et al.
Journal of Cardiovascular Pharmacology
|
June 25, 2008
Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy
Romualdo Belardinelli, Giovanni Cianci, Mirko Gigli, et al.
European Heart Journal
|
July 23, 2003
Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing
Romualdo Belardinelli, Francesca Lacalaprice, Flavia Carle, et al.
Clinical Colorectal Cancer
|
July 25, 2008
A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: predictive value of early specific toxicities
Teresa Gamucci, Fabrizio Nelli, Giovanni Cianci, et al.
Oncotarget
|
March 28, 2020
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of <i>EGFR</i> mutations in NSCLC: a new algorithm for patient selection and personalized treatment
Fiamma Buttitta, Lara Felicioni, Alessia Di Lorito, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of the American College of Cardiology
|
September 25, 2012
10-year exercise training in chronic heart failure: a randomized controlled trial
Romualdo Belardinelli, Demetrios Georgiou, Giovanni Cianci, et al.
Journal of Cardiovascular Pharmacology
|
June 25, 2008
Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy
Romualdo Belardinelli, Giovanni Cianci, Mirko Gigli, et al.
European Heart Journal
|
July 23, 2003
Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing
Romualdo Belardinelli, Francesca Lacalaprice, Flavia Carle, et al.
Clinical Colorectal Cancer
|
July 25, 2008
A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: predictive value of early specific toxicities
Teresa Gamucci, Fabrizio Nelli, Giovanni Cianci, et al.
Oncotarget
|
March 28, 2020
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of <i>EGFR</i> mutations in NSCLC: a new algorithm for patient selection and personalized treatment
Fiamma Buttitta, Lara Felicioni, Alessia Di Lorito, et al.
Page
of 1